CARsgen Therapeutics Holdings Ltd
HKEX:2171

Watchlist Manager
CARsgen Therapeutics Holdings Ltd Logo
CARsgen Therapeutics Holdings Ltd
HKEX:2171
Watchlist
Price: 15.94 HKD 2.57% Market Closed
Market Cap: 9.1B HKD

Intrinsic Value

CARsgen Therapeutics Holdings Ltd's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CARsgen Therapeutics Holdings Ltd stock under the Base Case scenario is 9.33 HKD. Compared to the current market price of 15.94 HKD, CARsgen Therapeutics Holdings Ltd is Overvalued by 41%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
9.33 HKD
Overvaluation 41%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
CARsgen Therapeutics Holdings Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
CARsgen Therapeutics Holdings Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CARsgen Therapeutics Holdings Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

CARsgen Therapeutics Holdings Ltd
HKEX:2171
CN
Biotechnology
Market Cap
9.1B HKD
IPO
Jun 18, 2021
CN
Biotechnology
Market Cap
9.1B HKD
IPO
Jun 18, 2021
Price
HK$false
EPS
ÂĄfalse
AI Assistant
AI Assistant
Ask me anything about CARsgen Therapeutics Holdings Ltd
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
CARsgen Therapeutics Holdings Ltd

Balance Sheet Decomposition
CARsgen Therapeutics Holdings Ltd

Current Assets 1.5B
Cash & Short-Term Investments 1.5B
Receivables 28.1m
Other Current Assets 23.1m
Non-Current Assets 142.8m
PP&E 123.9m
Intangibles 2.9m
Other Non-Current Assets 15.9m
Efficiency

Free Cash Flow Analysis
CARsgen Therapeutics Holdings Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
CARsgen Therapeutics Holdings Ltd

Revenue
39.4m CNY
Cost of Revenue
-24.7m CNY
Gross Profit
14.7m CNY
Operating Expenses
-822.9m CNY
Operating Income
-808.2m CNY
Other Expenses
10.1m CNY
Net Income
-798.1m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

CARsgen Therapeutics Holdings Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
ROE is Increasing
Positive 3-Years Revenue Growth
Positive Gross Profit
26/100
Profitability
Score

CARsgen Therapeutics Holdings Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

CARsgen Therapeutics Holdings Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Low D/E
69/100
Solvency
Score

CARsgen Therapeutics Holdings Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
CARsgen Therapeutics Holdings Ltd

Wall Street analysts forecast CARsgen Therapeutics Holdings Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CARsgen Therapeutics Holdings Ltd is 9.24 HKD with a low forecast of 9.15 HKD and a high forecast of 9.51 HKD.

Lowest
Price Target
9.15 HKD
43% Downside
Average
Price Target
9.24 HKD
42% Downside
Highest
Price Target
9.51 HKD
40% Downside
View Analyst Estimates
View Analyst Estimates

Dividends

CARsgen Therapeutics Holdings Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for CARsgen Therapeutics Holdings Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one CARsgen Therapeutics Holdings Ltd stock?

The intrinsic value of one CARsgen Therapeutics Holdings Ltd stock under the Base Case scenario is 9.33 HKD.

Is CARsgen Therapeutics Holdings Ltd stock undervalued or overvalued?

Compared to the current market price of 15.94 HKD, CARsgen Therapeutics Holdings Ltd is Overvalued by 41%.

Back to Top